US EditionPublished • loading... • Updated
Palvella Appoints Kent Taylor as Senior Vice President of Sales
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Palvella Appoints Kent Taylor as Senior Vice President of Sales
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) has appointed Kent Taylor as senior vice president of sales to lead its U.S. commercial organization ahead of a potential product launch. Taylor will oversee sales strategy and team development as the company prepares for a possible U.S. launch of QTORIN rapamycin, an investigational treatment for microcystic lymphatic malformations, a rare genetic condition with no approved therapies. Taylor…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
